Rubicon Company Profile
✉ Email this page to a colleague
What is the competitive landscape for RUBICON, and what generic and branded alternatives to RUBICON drugs are available?
RUBICON has sixty-one approved drugs.
There is one tentative approval on RUBICON drugs.
Summary for Rubicon
| US Patents: | 0 |
| Tradenames: | 51 |
| Ingredients: | 51 |
| NDAs: | 61 |
Drugs and US Patents for Rubicon
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rubicon | METOLAZONE | metolazone | TABLET;ORAL | 215184-003 | Aug 20, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Rubicon | POTASSIUM CHLORIDE | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 215725-002 | Jul 25, 2022 | AB3 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Rubicon | PANTOPRAZOLE SODIUM | pantoprazole sodium | TABLET, DELAYED RELEASE;ORAL | 090807-002 | May 2, 2012 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Rubicon | METOPROLOL TARTRATE | metoprolol tartrate | TABLET;ORAL | 200981-005 | Aug 21, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Rubicon | NITROGLYCERIN | nitroglycerin | TABLET;SUBLINGUAL | 209779-003 | May 3, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Rubicon | LABETALOL HYDROCHLORIDE | labetalol hydrochloride | TABLET;ORAL | 211953-001 | Aug 18, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
